Horizon Kinetics Medical ETF Rating

$28.49
-0.20 (-0.70%)
(As of 05/10/2024 ET)

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.59

Holdings in MEDX have an aggregate rating of Moderate Buy based on 342 analyst ratings issued in the past year covering 32 companies (88.5% of the portfolio).

MEDX Aggregate Price Target

$37.96
33.22% Upside
High Prediction$50.64
Average Prediction$37.96
Low Prediction$26.45

Holdings in MEDX have an aggregate price target of $37.96 and a range of $26.45 to $50.64 covering 32 companies (88.5% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
Moderate Buy
17 Moderate Buy rating(s)
Hold
10 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
1 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 32 MEDX Holdings

Weight
In ETF
CompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
15.09%
Eli Lilly and Companyd stock logo
LLY
Eli Lilly and Company
$760.26
-1.5%
5 of 5 stars
2.84$757.95 -0.3%19Earnings Report
Dividend Announcement
Short Interest ↓
7.84%
AbbVie Inc.d stock logo
ABBV
AbbVie
$160.75
+0.2%
4 of 5 stars
2.77$174.31 8.4%13Earnings Report
Short Interest ↑
5.53%
Amgen Inc.d stock logo
AMGN
Amgen
$310.15
-0.9%
5 of 5 stars
2.52$305.65 -1.5%21Analyst Forecast
5.32%
AstraZeneca PLCd stock logo
AZN
AstraZeneca
$77.18
-0.6%
2 of 5 stars
2.57$81.00 4.9%7
5.24%
Bristol-Myers Squibbd stock logo
BMY
Bristol-Myers Squibb
$44.94
+0.4%
5 of 5 stars
2.11$60.00 33.5%19Short Interest ↓
Analyst Revision
5.19%
Johnson & Johnsond stock logo
JNJ
Johnson & Johnson
$149.91
+0.0%
5 of 5 stars
2.46$175.86 17.3%13Short Interest ↑
Analyst Revision
5.13%
Merck & Co., Inc.d stock logo
MRK
Merck & Co., Inc.
$130.03
-0.2%
5 of 5 stars
2.58$131.33 1.0%12
4.11%
Pfizer Inc.d stock logo
PFE
Pfizer
$28.02
-0.6%
5 of 5 stars
2.38$36.00 28.5%15Options Volume
3.93%
Regeneron Pharmaceuticals, Inc.d stock logo
REGN
Regeneron Pharmaceuticals
$973.80
+0.6%
4 of 5 stars
2.70$981.71 0.8%20
3.63%
Biogen Inc.d stock logo
BIIB
Biogen
$221.50
-0.6%
5 of 5 stars
2.65$288.46 30.2%26Positive News
3.59%
CRISPR Therapeutics AGd stock logo
CRSP
CRISPR Therapeutics
$51.17
-4.4%
3 of 5 stars
2.35$74.43 45.5%17Earnings Report
Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
3.37%
Alkermes plcd stock logo
ALKS
Alkermes
$24.05
-0.9%
5 of 5 stars
2.50$35.38 47.1%10Positive News
3.14%
Ionis Pharmaceuticals, Inc.d stock logo
IONS
Ionis Pharmaceuticals
$39.08
-1.0%
4 of 5 stars
2.71$59.54 52.4%14Earnings Report
Analyst Forecast
Insider Selling
Short Interest ↓
Gap Down
2.80%
GSK plcd stock logo
GSK
GSK
$45.08
+0.9%
3 of 5 stars
2.405Options Volume
2.53%
Alnylam Pharmaceuticals, Inc.d stock logo
ALNY
Alnylam Pharmaceuticals
$150.47
-0.6%
4 of 5 stars
2.59$216.19 43.7%17Analyst Forecast
Short Interest ↑
Analyst Revision
1.97%
Bicycle Therapeutics plcd stock logo
BCYC
Bicycle Therapeutics
$22.89
-2.9%
2 of 5 stars
2.86$46.86 104.7%7Short Interest ↓
1.87%
Intellia Therapeutics, Inc.d stock logo
NTLA
Intellia Therapeutics
$24.46
-1.6%
4 of 5 stars
2.69$67.00 173.9%13Analyst Forecast
News Coverage
1.36%
Beam Therapeutics Inc.d stock logo
BEAM
Beam Therapeutics
$21.26
-5.7%
1 of 5 stars
2.38$40.18 89.0%13Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
1.09%
Galectin Therapeutics Inc.d stock logo
GALT
Galectin Therapeutics
$3.03
-6.8%
1 of 5 stars
3.00$11.00 263.0%1Short Interest ↑
Negative News
1.04%
Editas Medicine, Inc.d stock logo
EDIT
Editas Medicine
$5.32
-4.3%
3 of 5 stars
2.50$13.90 161.3%10Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
1.00%
Lantern Pharma Inc.d stock logo
LTRN
Lantern Pharma
$6.16
-9.5%
0 of 5 stars
2.001Gap Down
0.71%
Haleon plcd stock logo
HLN
Haleon
$8.25
-0.1%
2 of 5 stars
2.605Positive News
0.56%
Replimune Group, Inc.d stock logo
REPL
Replimune Group
$6.41
-4.8%
4 of 5 stars
3.00$37.67 487.6%3Upcoming Earnings
0.50%
GE HealthCare Technologies Inc.d stock logo
GEHC
GE HealthCare Technologies
$83.40
+0.8%
4 of 5 stars
2.64$95.00 13.9%11Short Interest ↑
0.48%
2seventy bio, Inc.d stock logo
TSVT
2seventy bio
$4.38
-1.1%
2 of 5 stars
2.44$12.86 193.5%9Analyst Forecast
News Coverage
0.39%
Allogene Therapeutics, Inc.d stock logo
ALLO
Allogene Therapeutics
$2.76
-3.5%
2 of 5 stars
2.71$13.50 389.1%7Short Interest ↑
0.39%
Sandoz Group AGd stock logo
SDZNY
Sandoz Group
$35.98
+2.9%
3 of 5 stars
3.003Short Interest ↓
Gap Up
0.24%
Viatris Inc.d stock logo
VTRS
Viatris
$11.16
-0.5%
1 of 5 stars
1.33$11.00 -1.4%3Earnings Report
Dividend Announcement
News Coverage
0.21%
bluebird bio, Inc.d stock logo
BLUE
bluebird bio
$1.06
-5.4%
2 of 5 stars
2.27$5.74 441.9%11Upcoming Earnings
0.10%
Pacific Biosciences of California, Inc.d stock logo
PACB
Pacific Biosciences of California
$1.77
+2.9%
3 of 5 stars
2.53$7.68 334.0%15Earnings Report
Analyst Forecast
News Coverage
0.09%
Salarius Pharmaceuticals, Inc.d stock logo
SLRX
Salarius Pharmaceuticals
$0.50
-2.0%
0 of 5 stars
2.001Short Interest ↓
News Coverage
Positive News
0.05%
Mural Oncology plcd stock logo
MURA
Mural Oncology
$3.78
-0.5%
2 of 5 stars
3.00$13.00 243.9%1Short Interest ↑
This page (NASDAQ:MEDX) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners